Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2475265

Words CHORD
Image
Image description
Status registered: Registered/protected
Priority date 23 Feb 2024 (Convention)
Classes 5, 40, 42
Kind Word
Dates
Renewal due 19 Aug 2034
Registration advertised / published 31 Mar 2025
Entered on Register 31 Mar 2025
Acceptance advertised / published 22 Jan 2025
Acceptance 22 Jan 2025
Filing 19 Aug 2024
Registered from 19 Aug 2024

Owner Address for service
Korro Bio, Inc.
PHILLIPS ORMONDE FITZPATRICK

Goods & Services
Class 5: Oligonucleotide preparations for the treatment of genetic diseases
Class 40: Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others; Custom manufacture and processing of human cells for medical purposes for others; Treatment of therapeutic cells for others, namely, pharmacological treatment and processing of therapeutic cells to modify their function for therapeutic purposes
Class 42: Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Pharmaceutical research and development incorporating artificial intelligence; Pharmaceutical research and development incorporating genetic learning; Scientific and industrial research; Scientific and industrial research incorporating artificial intelligence; Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning

Convention details
Date 23 Feb 2024
Number 98/417,765
Country UNITED STATES OF AMERICA
Goods & Services
Class 5:
Oligonucleotide preparations for the treatment of genetic diseases
Class 40:
Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others;Custom manufacture and processing of human cells for medical purposes for others;Treatment of therapeutic cells for others, namely, pharmacological treatment and processing of therapeutic cells to modify their function for therapeutic purposes
Class 42:
Pharmaceutical research and development;Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development;Pharmaceutical research and development incorporating artificial intelligence;Pharmaceutical research and development incorporating genetic learning;Scientific and industrial research;Scientific and industrial research incorporating artificial intelligence;Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning

Indexing constituents
Word Image